SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000921895-18-000530
Filing Date
2018-02-13
Accepted
2018-02-12 21:24:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO THE SCHEDULE 13G sc13ga210109002_02132018.htm SC 13G/A 56332
  Complete submission text file 0000921895-18-000530.txt   57862
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Subject) CIK: 0001388320 (see all company filings)

IRS No.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-82467 | Film No.: 18598826
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1275 YORK AVE. NEW YORK NY 10065
Business Address 1275 YORK AVE. NEW YORK NY 10065 212-639-2000
Memorial Sloan-Kettering Cancer Center (Filed by) CIK: 0001566787 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NY
Type: SC 13G/A